Cardiogenic and Myogenic Gene Expression in Mesenchymal Stem Cells After 5-Azacytidine Treatment

OBJECTIVE: 5-Azacytidine is a hypomethylating agent that is used for the treatment of myelodysplastic syndrome. This histone modifier is widely employed and plays a nonspecific role in influencing the differentiation capability of stem cells. The ability of bone marrow mesenchymal stem cells to diff...

Full description

Bibliographic Details
Main Authors: Aungkura Supokawej, Pakpoom Kheolamai, Kuneerat Nartprayut, Yaowalak U-pratya, Sirikul Manochantr, Methichit Chayosumrit, Surapol Issaragrisil
Format: Article
Language:English
Published: Galenos Publishing House 2013-06-01
Series:Turkish Journal of Hematology
Subjects:
Online Access:https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-95777